Vivasure wins FDA IDE, receives €30M from Haemonetics

Vivasure Medical announced that it received FDA investigational device exemption (IDE) to advance a clinical study of its PerQseal device.

Related Keywords

Ireland ,Vivasure Perqseal ,Health Economics Fund ,Life Sciences ,European Investment Bank ,Vivasure Medical ,Ireland Based Vivasure ,Vivasure Patch ,Andrew Glass ,Stew Strong ,Fountain Healthcare Partners ,Orchestra Biomed ,Economics Fund ,Evonik Venture ,Enterprise Ireland ,European Investment ,